Surfing the web, I uncovered these new items worth sharing:

• Researchers at Case Western Reserve University have developed a computer program to distinguish between radiation necrosis and recurrent brain cancer. In a comparison, the program outperformed a pair of neruoradiologists in diagnostic accuracy. Read more on this development in the American Journal of Neuroradiology.
• A new study outlines the development of a synthetic polymer capable of transporting a drug into lung cancer cells without affecting normal lung cells. The discovery that nanoparticles can be selective may have huge implications for patient outcomes.  The research has been published in PNAS.
• A new immunotherapy treatment has shown dramatic promise in treating patients with advanced pancreatic cancer. Patients enrolled in a trial receiving the new treatment, IMM-101 with chemotherapy, showed significant survival advantage compared to patients treated with only chemotherapy. Further details provided in the British Journal of Cancer.
• A recent study in the New England Journal of Medicine found that “active monitoring” of prostate cancer patients does not increase death rates as compared to patients that had undergone surgery or radiation.